Literature DB >> 16750200

Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma.

Jian Huang1, Hai-Hui Sheng, Ting Shen, Yuan-Jie Hu, Hua-Sheng Xiao, Qin Zhang, Qing-Hua Zhang, Ze-Guang Han.   

Abstract

Human hepatocellular carcinoma (HCC) is one of the most common tumors worldwide, in which the genetic mechanisms of oncogenesis are still unclear. To investigate whether the genomic DNA copy number alterations may contribute to primary HCC, the cDNA microarray-based comparative genomic hybridization (CGH) analysis was here performed in 41 primary HCC infected by hepatitis B virus and 12 HCC cell lines. The resulting data showed that, on average, 7.25% of genome-wide DNA copy numbers was significantly altered in those samples (4.61+/-2.49% gained and 2.64+/-1.78% lost). Gains involving 1q, 6p, 8q and 9p were frequently observed in these cases; and whilst, losses involving Ip, 16q and 19p occurred in most patients. To address the correlation between the alteration of genomic DNA copy numbers and transcriptional expression, the same cDNA microarray was further applied in 20 HCC specimens and all available cell lines to figure out the gene expression profiles of those samples. Interestingly, the genomic DNA copy number alterations of most genes appeared not to be in generally parallel with the corresponding transcriptional expression. However, the transcriptional deregulation of a few genes, such as osteopontin (SPP1), transgelin 2 (TAGLN2) and PEG10, could be ascribed partially to their genomic aberrations, although the many alternative mechanisms could be involved in the deregulation of these genes. In general, this work would provide new insights into the genetic mechanisms in hepatocarcinogenesis associated with hepatitis B virus through the comprehensive survey on correlation between genomic DNA copy number alterations and transcriptional expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750200     DOI: 10.1016/j.febslet.2006.05.032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.

Authors:  Derek Y Chiang; Augusto Villanueva; Yujin Hoshida; Judit Peix; Philippa Newell; Beatriz Minguez; Amanda C LeBlanc; Diana J Donovan; Swan N Thung; Manel Solé; Victoria Tovar; Clara Alsinet; Alex H Ramos; Jordi Barretina; Sasan Roayaie; Myron Schwartz; Samuel Waxman; Jordi Bruix; Vincenzo Mazzaferro; Azra H Ligon; Vesna Najfeld; Scott L Friedman; William R Sellers; Matthew Meyerson; Josep M Llovet
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

2.  Molecular mechanisms underlying the cholesterol-lowering effect of Ginkgo biloba extract in hepatocytes: a comparative study with lovastatin.

Authors:  Zuo-quan Xie; Gai Liang; Lu Zhang; Qi Wang; Yi Qu; Yang Gao; Li-bo Lin; Sai Ye; Ji Zhang; Hui Wang; Guo-ping Zhao; Qing-hua Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

3.  Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.

Authors:  Ke-Feng Lei; Bing-Ya Liu; Xiao-Qing Zhang; Xiao-Long Jin; Yan Guo; Min Ye; Zheng-Gang Zhu
Journal:  Exp Ther Med       Date:  2011-09-21       Impact factor: 2.447

4.  Adenoviral gene therapy in hepatocellular carcinoma: a review.

Authors:  Iván Lyra-González; Laura Esther Flores-Fong; Ignacio González-García; David Medina-Preciado; Juan Armendáriz-Borunda
Journal:  Hepatol Int       Date:  2012-04-25       Impact factor: 6.047

5.  Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.

Authors:  Jin-Cai Wu; Bing-Sheng Sun; Ning Ren; Qing-Hai Ye; Lun-Xiu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-16       Impact factor: 4.553

6.  Data integration in genetics and genomics: methods and challenges.

Authors:  Jemila S Hamid; Pingzhao Hu; Nicole M Roslin; Vicki Ling; Celia M T Greenwood; Joseph Beyene
Journal:  Hum Genomics Proteomics       Date:  2009-01-12

7.  Suppressive effects of genomic imprinted gene PEG10 on hydrogen peroxide-induced apoptosis in L02 cells.

Authors:  Yao Liu; Huanjun Huang; Jusheng Lin; Qiang Zhang; Jinquan Tan; Jinghua Ren
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

8.  Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.

Authors:  Jian Huang; Da-Li Zheng; Feng-Song Qin; Na Cheng; Hui Chen; Bing-Bing Wan; Yu-Ping Wang; Hua-Sheng Xiao; Ze-Guang Han
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808

9.  The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.

Authors:  H Yoshino; T Chiyomaru; H Enokida; K Kawakami; S Tatarano; K Nishiyama; N Nohata; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2011-02-08       Impact factor: 7.640

10.  miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.

Authors:  Nijiro Nohata; Yaeko Sone; Toyoyuki Hanazawa; Miki Fuse; Naoko Kikkawa; Hirofumi Yoshino; Takeshi Chiyomaru; Kazumori Kawakami; Hideki Enokida; Masayuki Nakagawa; Makio Shozu; Yoshitaka Okamoto; Naohiko Seki
Journal:  Oncotarget       Date:  2011 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.